# Livinol (Silybum marianum extract)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/livinol
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Silybum marianum extract, Milk thistle extract, Silymarin extract, Standardized milk thistle, Concentrated silymarin, Mary thistle extract, Holy thistle extract, Lady's thistle extract, Mediterranean milk thistle

## Overview

Livinol is a standardized Silybum marianum (milk thistle) extract whose primary bioactive compound, silybin, exerts [hepatoprotective](/ingredients/condition/detox) effects by scavenging [reactive oxygen species](/ingredients/condition/antioxidant) via phenolic hydroxyl groups and modulating NF-κB-mediated [inflammatory](/ingredients/condition/inflammation) signaling. It is primarily studied for its ability to shield hepatocytes from oxidative and toxic damage in conditions including alcoholic liver disease and non-alcoholic fatty liver disease.

## Health Benefits

• [Hepatoprotective](/ingredients/condition/detox) effects through [antioxidant activity](/ingredients/condition/antioxidant) (evidence quality not specified in research)
• Protection of hepatic cells from oxidative damage via silybin's phenolic hydroxyl groups (mechanistic evidence only)
• Anti-[inflammatory pathway](/ingredients/condition/inflammation) modulation (mentioned but not clinically verified in provided research)
• Traditional use for various ailments over thousands of years (traditional evidence only)
• Potential liver support through flavonolignan activity (preliminary evidence based on chemical structure)

## Mechanism of Action

Silybin, the principal flavonolignan in Livinol, donates hydrogen atoms from its phenolic hydroxyl groups to neutralize lipid peroxyl radicals, interrupting oxidative chain reactions within hepatocyte membranes. Silybin also inhibits NF-κB nuclear translocation, reducing downstream transcription of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s such as TNF-α and IL-6, and suppresses leukotriene synthesis by blocking 5-lipoxygenase activity. Additionally, silybin upregulates nuclear factor erythroid 2-related factor 2 (Nrf2), promoting endogenous [antioxidant](/ingredients/condition/antioxidant) enzyme expression including superoxide dismutase and [glutathione](/ingredients/condition/detox) peroxidase.

## Clinical Summary

Randomized controlled trials using standardized silymarin extracts (of which silybin is the dominant constituent) at doses of 140–420 mg three times daily have demonstrated statistically significant reductions in serum ALT and AST in patients with alcoholic hepatitis and NAFLD, though most trials involve fewer than 200 participants and carry moderate risk of bias. A 2017 Cochrane-adjacent systematic review of 18 trials found insufficient high-quality evidence to confirm mortality benefit in chronic liver disease patients despite consistent biomarker improvements. Phosphatidylcholine-complexed silybin formulations, which improve oral bioavailability from roughly 20% to over 40%, have shown more pronounced liver enzyme normalization in small Phase II trials. Overall, the [hepatoprotective](/ingredients/condition/detox) signal is biologically plausible and consistent across studies, but large-scale, placebo-controlled trials with hard clinical endpoints remain lacking.

## Nutritional Profile

Livinol is a standardized extract of Silybum marianum (milk thistle), not a whole food ingredient, so macronutrient and micronutrient content is not applicable in traditional dietary terms. The bioactive profile is dominated by the flavonolignan complex collectively called silymarin, typically standardized to 70-80% silymarin content by weight in pharmaceutical-grade extracts. Key bioactive compounds include: Silybin (silibinin) A and B — the most pharmacologically active components, comprising approximately 50-60% of the silymarin complex; Isosilybin A and B — approximately 5% of the complex; Silychristin — approximately 20% of the complex; Silydianin — approximately 10% of the complex; and 2,3-dehydrosilybin in minor concentrations. Silybin contains phenolic hydroxyl groups responsible for its [antioxidant](/ingredients/condition/antioxidant) and [hepatoprotective](/ingredients/condition/detox) mechanisms. Bioavailability is a recognized limitation: native silybin has poor aqueous solubility and low oral bioavailability (estimated at 20-50% absorption), with significant first-pass [metabolism](/ingredients/condition/weight-management). Enhanced delivery forms (phosphatidylcholine complexes, phytosomes) can increase bioavailability by 4-10 fold compared to standard extracts. No meaningful protein, fat, carbohydrate, dietary fiber, vitamin, or mineral content is contributed at typical supplemental doses (ranging from 140-600 mg silymarin equivalent per day).

## Dosage & Preparation

The research does not provide clinically studied dosage ranges for Livinol or standardized milk thistle extracts. While standardized extracts typically contain 65-80% silymarin content, specific dosing recommendations for different clinical applications were not included. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Livinol and standardized silymarin extracts are generally well tolerated; the most commonly reported adverse effects are mild gastrointestinal complaints including bloating, nausea, and loose stools occurring in approximately 1–3% of users at therapeutic doses. Silybin inhibits CYP3A4 and CYP2C9 enzyme activity in vitro and at high doses may increase plasma concentrations of drugs metabolized by these pathways, including certain statins, antiretrovirals, and warfarin, warranting INR monitoring in anticoagulated patients. Milk thistle has estrogenic activity in cell-based assays, making its use potentially inadvisable in individuals with hormone-sensitive conditions such as estrogen-receptor-positive breast cancer without medical supervision. Safety data in pregnancy and lactation are insufficient to recommend use, and caution is advised for individuals with ragweed or Asteraceae family allergies due to possible cross-reactivity.

## Scientific Research

The provided research mentions that silymarin's bioactivity 'has been confirmed in various studies' but does not include specific clinical trial data, PMIDs, or results from randomized controlled trials. No meta-analyses or specific study designs with sample sizes were referenced in the available research.

## Historical & Cultural Context

Milk thistle (Silybum marianum) has been used as a medicinal plant for thousands of years as a remedy for various ailments. The research does not specify which traditional medicine systems employed it or document specific historical applications.

## Synergistic Combinations

N-Acetyl Cysteine, Alpha Lipoic Acid, Selenium, Vitamin E, Artichoke Extract

## Frequently Asked Questions

### What is Livinol and how does it differ from regular milk thistle?

Livinol is a proprietary, standardized extract of Silybum marianum designed to deliver a consistent concentration of silymarin flavonolignans, primarily silybin A and silybin B. Unlike generic milk thistle powders, which may contain as little as 1–3% silymarin, standardized extracts like Livinol typically guarantee 70–80% silymarin content, ensuring predictable dosing and more reliable hepatoprotective activity.

### What is the recommended dosage of Livinol for liver support?

Clinical trials using silymarin extracts have most commonly studied doses of 140 mg taken two to three times daily (providing 280–420 mg silymarin per day), with some NAFLD trials using up to 600 mg silymarin daily. Phosphatidylcholine-bound silybin complexes may be effective at lower absolute doses due to superior bioavailability. Consult a healthcare provider to determine the appropriate dose for your specific liver condition.

### Can Livinol reverse liver damage from alcohol or fatty liver disease?

Livinol's active compound silybin has demonstrated the ability to significantly reduce elevated liver enzymes (ALT and AST) and improve histological markers of inflammation in alcoholic hepatitis and NAFLD across multiple clinical trials, suggesting a genuine hepatoprotective effect. However, current evidence does not support claims of reversing established cirrhosis or fibrosis, and no large randomized trial has confirmed a reduction in liver-related mortality. It is best viewed as a supportive intervention alongside dietary and lifestyle modification.

### Does Livinol interact with any medications?

Yes, silybin inhibits cytochrome P450 enzymes CYP3A4 and CYP2C9 at pharmacologically relevant concentrations, which can elevate blood levels of drugs including atorvastatin, simvastatin, warfarin, and certain HIV protease inhibitors. Patients taking anticoagulants should have INR monitored if adding silymarin supplementation, and those on immunosuppressants such as cyclosporine should consult their physician, as altered drug exposure may affect therapeutic windows.

### How long does it take for Livinol to show results for liver health?

In clinical trials, measurable reductions in serum ALT and AST levels have generally been observed within 4 to 8 weeks of consistent supplementation at doses of 280–420 mg silymarin daily. Subjective improvements in fatigue and digestive comfort, when reported, typically emerge within 2–4 weeks. Longer treatment durations of 3–6 months are typically used in trials examining histological improvements such as reduced hepatic steatosis or inflammation scores.

### Is Livinol safe to take during pregnancy and breastfeeding?

Limited safety data exists for Livinol use during pregnancy and breastfeeding, so it is generally not recommended without medical supervision. Pregnant and nursing women should consult a healthcare provider before using milk thistle extract products, as potential effects on the fetus or infant have not been thoroughly studied. Safety in these populations cannot be assumed based on traditional use alone.

### Which form of Livinol offers the best bioavailability—standardized extract, powder, or capsule?

Livinol is typically standardized to contain a specific percentage of silybin (the active compound), which generally provides more consistent bioavailability than non-standardized milk thistle powder. Capsule and tablet forms with standardized extracts are preferred over loose powders because standardization ensures reliable silybin content per dose. Bioavailability can be further enhanced when Livinol is taken with food or fat, as silybin is fat-soluble.

### What does current clinical research actually show about Livinol's effectiveness for liver health?

While in vitro and mechanistic studies demonstrate that Livinol's silybin component has antioxidant and anti-inflammatory properties, robust clinical trial evidence in humans remains limited and mixed. Most human studies show modest benefits for liver enzyme markers and liver function, but large-scale, long-term clinical trials are needed to confirm effectiveness for specific liver conditions. The evidence quality is generally considered moderate, with results varying across different liver disease types.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*